These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7882290)

  • 1. Joint meeting on the feasibility of a study of screening premenopausal women (40-49 years) for breast cancer: April 20-21, 1994.
    Eyre H; Sondik E; Smith RA; Kessler L
    Cancer; 1995 Mar; 75(6):1391-403. PubMed ID: 7882290
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
    Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
    Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening in premenopausal women: current recommendations and opportunities for research.
    Mettlin C; Murphy GP
    Ann Med; 1995 Aug; 27(4):461-5. PubMed ID: 8519507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
    Warner E; Plewes DB; Shumak RS; Catzavelos GC; Di Prospero LS; Yaffe MJ; Goel V; Ramsay E; Chart PL; Cole DE; Taylor GA; Cutrara M; Samuels TH; Murphy JP; Murphy JM; Narod SA
    J Clin Oncol; 2001 Aug; 19(15):3524-31. PubMed ID: 11481359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
    Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993.
    Eckhardt S; Badellino F; Murphy GP
    Int J Cancer; 1994 Jan; 56(1):1-5. PubMed ID: 7903286
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass screening for breast cancer.
    Björnsson S; Brekkan A; Tulinius H
    Scand J Soc Med; 1986; 14(1):3-6. PubMed ID: 3704578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.
    von Minckwitz G; Loibl S; Jackisch C; Paepke S; Nestle-Kraemling C; Lux MP; Maass N; Schmutzler R; du Bois A; Wallwiener D; Vescia S; Budischewski K; Kaufmann M
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2141-9. PubMed ID: 21795500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer.
    Liljegren A; von Wachenfeldt A; Azavedo E; Eloranta S; Grundström H; Ståhlbom AK; Sundbom A; Sundén P; Svane G; Ulitzsch D; Arver B
    Breast Cancer Res Treat; 2018 Apr; 168(3):655-666. PubMed ID: 29318406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on screening breast MRI in high-risk women.
    Boetes C
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):149-58, viii-ix. PubMed ID: 21419331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
    Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
    Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening: early recognition.
    Costanza ME; Edmiston KL
    Compr Ther; 1997 Jan; 23(1):7-12. PubMed ID: 9067076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
    Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
    Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
    Miller AB; To T; Baines CJ; Wall C
    Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of screening and prevention in women at very high risk of breast cancer.
    Evans D; Lalloo F; Shenton A; Boggis C; Howell A
    Lancet; 2001 Sep; 358(9285):889-90. PubMed ID: 11567707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
    Larouche G; Chiquette J; Pelletier S; Simard J; Dorval M
    Fam Cancer; 2017 Jan; 16(1):35-40. PubMed ID: 27554086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.